Moderna, Inc.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $206.80
- 52-Week Range
- $22.28 – $280.80
- Market Cap
- $79.63B
- P/E (TTM)
- —
- EPS (TTM)
- -7.04
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 11.63
- PEG Ratio
- —
- Return on Equity
- -34.50%
- Return on Assets
- -9.96%
- Gross Margin
- -42.02%
- Operating Margin
- -80.79%
- Profit Margin
- -110.45%
- Current Ratio
- 3.62
- Debt/Equity
- 0.62
- Total Debt
- $4.23B
- Free Cash Flow
- $-584.50M
- Revenue Growth
- 29.20%
- Earnings Growth
- —
- Enterprise Value
- $78.68B
Market Snapshot
About
Biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines. Known for developing one of the first COVID-19 vaccines. Works on treatments for infectious diseases, immuno-oncology, rare diseases, and cardiovascular conditions using mRNA technology.